MapLight Therapeutics, Inc. (MPLT) earnings
Quarterly results of MapLight Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
MapLight Therapeutics, Inc. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) MapLight Therapeutics, Inc. reported revenue of - and a net loss of $60.2M.
Diluted earnings per share were -$1.32.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$60.2M | -$1.32 |
| Q1 FY2026 | - | - | -$60.7M | -$1.34 |
| Q4 FY2025 | - | - | -$79.5M | - |
| Q3 FY2025 | - | - | -$29.4M | -$37.18 |
| Q3 FY2025 | - | - | -$29.8M | -$39.11 |
| Q3 FY2025 | - | - | -$22.3M | -$29.33 |
| Q4 FY2025 | - | - | -$21.2M | - |
| Q3 FY2025 | - | - | -$19M | -$25.08 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is MapLight Therapeutics, Inc.'s next earnings date?
MapLight Therapeutics, Inc. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Get an email when MPLT reports
Follow MPLT and we email you its next results the day they are filed, with the numbers explained.